<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> is a major <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurologic disorder</z:e> and a leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>We compared neuroprotective effects of single or combination therapy of <z:chebi fb="0" ids="2668">amlodipine</z:chebi> (AM) and <z:chebi fb="0" ids="39548">atorvastatin</z:chebi> (AT) in such a <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> model <z:chebi fb="3" ids="16646">Zucker</z:chebi> rat after 90 min of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>The animals were pretreated with vehicle, AM, AT, or the combination of AM plus AT for 28 days, and at 24h of tMCAO, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and immunohistochemical analyses were performed </plain></SENT>
<SENT sid="3" pm="."><plain>The combination of AM plus AT treatment decreased the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume stronger than each single treatment with AM or AT </plain></SENT>
<SENT sid="4" pm="."><plain>The numbers of positive cells of <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers such as 8-hydroxy-2'-deoxyguanosin (8-OHdG), <z:chebi fb="0" ids="32585">4-hydroxy-2-nonenal</z:chebi> (4-HNE), and advanced end glycation products (AGE) and <z:mp ids='MP_0001845'>inflammation</z:mp> markers such as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-Î±) and monocyte chemoattractant protein-1(<z:chebi fb="17" ids="50099">MCP</z:chebi>-1) decreased dramatically in the combination-treated group compared with single AM- or AT-treated group </plain></SENT>
<SENT sid="5" pm="."><plain>The present study showed that single AM or AT treatment showed neuroprotective effects both with antioxidative and anti-inflammatory mechanisms, but combination therapy of AM plus AT presented a further synergistic benefit in <z:hpo ids='HP_0011009'>acute</z:hpo> ischemic neural damages </plain></SENT>
</text></document>